Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds.
| Website | http://www.mablink.com |
| Revenue | $15.5 million |
| Employees | 35 (3 on RocketReach) |
| Founded | 2018 |
| Address | 31 rue Gorge de Loup, Lyon, Auvergne-Rhône-Alpes 69009, FR |
| Technologies |
JavaScript
,
HTML
,
PHP
+16 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Antibody Drug Conjugates, Biotechnology, Adc Technology, Targeted Therapy, Cancer Therapeutics, Oncology, Bioconjugation, Drug Development, Immunotherapy, Therapeutic Solutions, Cancer Research, Drug Delivery, Innovative Therapies, Pharmaceutical, Precision Medicine, Molecular Therapeutics, Biopharma, Clinical Trials |
| Competitors | Thermo Fisher Scientific, MilliporeSigma, Bio-Rad Laboratories, Promega Corporation, abcam, R&D Systems, Cell Signaling Technology (CST), Fisher Scientific, PEPROTECH EC LTD +39 more (view full list) |
Looking for a particular Mablink Bioscience employee's phone or email?
Mablink Bioscience Questions
The Mablink Bioscience annual revenue was $15.5 million in 2026.
Carmela Dantas-Barbosa is the Director of Translational Research of Mablink Bioscience.
3 people are employed at Mablink Bioscience.
Mablink Bioscience is based in Lyon, Auvergne-Rhône-Alpes.
Top Mablink Bioscience Employees
Related Companies
